CNTX · Context Therapeutics Inc.
$0.63
+0.03 (+5.55%)
At close · Jul 24
Market Cap
$56.42M
Shares
91.88M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | CEO | $1,465,430 |
| Jennifer Minai-Azary | CFO | $866,139 |
| Alex Levit | Chief Legal Officer and Corporate Secretary | $816,671 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | CEO | $1,011,069 |
| Jennifer Minai-Azary | CFO | $698,968 |
| Alex Levit | Chief Legal Officer and Corporate Secretary | $670,653 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | CEO | $860,681 |
| Jennifer Minai-Azary | CFO | $606,676 |
| Alex Levit | Chief Legal Officer and Corporate Secretary | $582,148 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | CEO | $1,057,653 |
| Jennifer Minai-Azary | CFO | $680,668 |
| Alex Levit | Chief Legal Officer and Corporate Secretary | $653,100 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | CEO | $1,587,791 |
| Alex Levit | Chief Legal Officer and Corporate Secretary | $596,709 |
| Jennifer Minai-Azary | CFO | $322,175 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Martin Lehr | CEO | $250,000 |